Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Water. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL30148488 | 1.00 | — | — | |
| Water SCHEMBL1697791 | 1.00 | — | — | |
| Water SCHEMBL28297605 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL28521157 | 0.95 | — | — | |
| Water SCHEMBL5606409 | 0.95 | — | — | |
| Water SCHEMBL6729822 | 0.95 | — | — | |
| SCHEMBL3293884 | 0.95 | — | — | |
| SCHEMBL75613 | 0.95 | — | — | |
| SCHEMBL374360 | 0.95 | ALDH1A1 (0.30) | — | |
| Water SCHEMBL8973068 | 0.91 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 32983 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122094963-A | Cardioprotective lipids and methods of use | — | 2026-05-26 | — | — | CN | claimed |
| CN-122079857-A | Synthesis method of 6-chloro-7-fluoroisatin | — | 2026-05-26 | — | — | CN | claimed |
| CN-122075026-A | Method for dynamically and noninvasively evaluating influence of health-care product oral liquid on liver based on Micro-CT technology | — | 2026-05-26 | — | — | CN | claimed |
| CN-115652384-B | Electrolytic copper foil with special coarsening morphology and preparation method thereof | 九江德福科技股份有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-12617809-B2 | Cardioprotective lipid and method of use | SIGNPATH PHARMA, INC. (US) | 2026-05-05 | — | — | US | claimed |
| US-12594388-B2 | Device to deliver a predetermined amount of a substance to a natural orifice of the body | APTARGROUP, INC. (US) | 2026-04-07 | — | — | US | claimed |
| EP-3507371-B1 | COMPOSITIONS FOR TREATING DISEASES AND DISORDERS OF THE NERVOUS SYSTEM | UNIV RUTGERS (US) | 2026-01-28 | — | — | EP | claimed |
| EP-4511640-B1 | STABLE UV INDICATOR | INTELLEGO TECH AB SWEDEN (SE) | 2025-12-24 | — | — | EP | claimed |
| US-12474326-B2 | Treatment methods having reduced drug-related toxicity and methods of identifying the likelihood of patient harm from prescribed medications | TABULA RASA HEALTHCARE, INC. (US) | 2025-11-18 | — | — | US | claimed |
| WO-2025233421-A1 | TISSUE CLARIFYING SYSTEM AND METHOD THEREOF | FUNDACIÓN PARA LA INVESTIGACIÓN BIOMÉDICA DEL HOSPITAL GREGORIO MARAÑÓN (FIBHGM) (ES) | 2025-11-13 | — | — | WO | claimed |
| WO-1983003541-A1 | ANTAGONISM OF CENTRAL NERVOUS SYSTEM DRUGS BY THE ADMINISTRATION OF 4-AMINOPYRIDINE ALONE OR IN COMBINATION WITH OTHER DRUGS | UNIV GEORGIA RES FOUND (US) | 1983-10-27 | — | — | WO | claimed |
| US-4393183-A | STORAGE STABILITY, BONDING STRENGTH | TOAGOSEI CHEMICAL INDUSTRY CO., LTD. (JP) | 1983-07-12 | — | — | US | claimed |
| EP-0026894-B1 | PROCESS FOR THE PREPARATION OF ERYTHRO-ALPHA-2-PIPERIDYL-2,8-BIS (TRIFLUOROMETHYL)-4-QUINOLINE METHANOL | BASF Aktiengesellschaft (DE) | 1983-03-30 | — | — | EP | claimed |
| US-4285892-A | ETCHING OR DISSOLVING | SHINWA SEISAKUSHO CO., LTD. (JP) | 1981-08-25 | — | — | US | claimed |
| US-4208433-A | TREATING WITH A SYNERGISTIC SOLID | BARHAM HAROLD NATHAN (US) | 1980-06-17 | — | — | US | claimed |
| US-4175119-A | Composition and method to prevent accidental and intentional overdosage with psychoactive drugs | PORTER GARRY L | 1979-11-20 | — | — | US | claimed |
| US-4140687-A | Process for the preparation of 8-halodihydrocodeinone hydrohalides and codeine | MACFARIAN SMITH LIMITED (GB) | 1979-02-20 | — | — | US | claimed |
| US-4087278-A | SEEDICIDES | THE DOW CHEMICAL COMPANY (US) | 1978-05-02 | — | — | US | claimed |
| US-RE29616-E | DEHYDROHALOGENATION, ACID CATALYST | GENERAL ELECTRIC COMPANY (US) | 1978-04-25 | — | — | US | claimed |
| US-3979341-A | FLAME RETARDANT, INTUMESCENT | BORDEN PRODUCTS LIMITED (CA) | 1976-09-07 | — | — | US | claimed |